| Thomas Quinn, MD | |
|
12255 S 80th Ave, Palos Heights, IL 60463-1270 | |
| (708) 923-3388 | |
| (708) 923-3380 |
| Full Name | Thomas Quinn |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 9 Years |
| Location | 12255 S 80th Ave, Palos Heights, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811377757 | NPI | - | NPPES |
| 036145949 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 036145949 (Illinois) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 036145949 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Palos Community Hospital | Palos heights, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Dupage Physician Group | 5890696231 | 1003 |
News Archive
Public health officials in New York City have launched a successful program to locate HIV-positive patients who have been "lost to follow-up" and reconnect them with treatment services, reports a study published in AIDS, official journal of the International AIDS Society.
For small business owners, technicians, laboratory managers and method developers, a new FT-NIR spectrometer is designed to bring rapid and reliable analysis for quality control and material verification.
Aduro BioTech, a clinical-stage immunotherapy company, announced today the issuance of two important patents, the formation of a distinguished scientific advisory board, the addition of key members to its Board of Directors, and the reporting of preliminary top line long-term survival data from a Phase 1 clinical trial with 2 year follow-up.
"The goal of the WHO - amplified ... in the Universal Declaration of Human Rights - is to ensure the attainment by the entire world's people of the highest possible level of health," Calum Macpherson, director and vice president of the Windward Islands Research and Education Foundation, writes in a Devex opinion piece.
Researchers from A*STAR Institute of Microelectronics (IME) have developed a lateral silicon-based drug screening tool that has demonstrated simultaneous capture of 12 individual cells – 12 times higher throughput than conventional patch clamping. The device can be scaled up to allow 1536 cell-recordings simultaneously, permitting 16 times higher throughput than existing planar patch clamp approach.
› Verified 2 days ago
| Entity Name | Central Dupage Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033149844 PECOS PAC ID: 5890696231 Enrollment ID: O20040303000601 |
News Archive
Public health officials in New York City have launched a successful program to locate HIV-positive patients who have been "lost to follow-up" and reconnect them with treatment services, reports a study published in AIDS, official journal of the International AIDS Society.
For small business owners, technicians, laboratory managers and method developers, a new FT-NIR spectrometer is designed to bring rapid and reliable analysis for quality control and material verification.
Aduro BioTech, a clinical-stage immunotherapy company, announced today the issuance of two important patents, the formation of a distinguished scientific advisory board, the addition of key members to its Board of Directors, and the reporting of preliminary top line long-term survival data from a Phase 1 clinical trial with 2 year follow-up.
"The goal of the WHO - amplified ... in the Universal Declaration of Human Rights - is to ensure the attainment by the entire world's people of the highest possible level of health," Calum Macpherson, director and vice president of the Windward Islands Research and Education Foundation, writes in a Devex opinion piece.
Researchers from A*STAR Institute of Microelectronics (IME) have developed a lateral silicon-based drug screening tool that has demonstrated simultaneous capture of 12 individual cells – 12 times higher throughput than conventional patch clamping. The device can be scaled up to allow 1536 cell-recordings simultaneously, permitting 16 times higher throughput than existing planar patch clamp approach.
› Verified 2 days ago
| Entity Name | Rush Oak Park Nocturnist |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518260165 PECOS PAC ID: 6406032887 Enrollment ID: O20110519000475 |
News Archive
Public health officials in New York City have launched a successful program to locate HIV-positive patients who have been "lost to follow-up" and reconnect them with treatment services, reports a study published in AIDS, official journal of the International AIDS Society.
For small business owners, technicians, laboratory managers and method developers, a new FT-NIR spectrometer is designed to bring rapid and reliable analysis for quality control and material verification.
Aduro BioTech, a clinical-stage immunotherapy company, announced today the issuance of two important patents, the formation of a distinguished scientific advisory board, the addition of key members to its Board of Directors, and the reporting of preliminary top line long-term survival data from a Phase 1 clinical trial with 2 year follow-up.
"The goal of the WHO - amplified ... in the Universal Declaration of Human Rights - is to ensure the attainment by the entire world's people of the highest possible level of health," Calum Macpherson, director and vice president of the Windward Islands Research and Education Foundation, writes in a Devex opinion piece.
Researchers from A*STAR Institute of Microelectronics (IME) have developed a lateral silicon-based drug screening tool that has demonstrated simultaneous capture of 12 individual cells – 12 times higher throughput than conventional patch clamping. The device can be scaled up to allow 1536 cell-recordings simultaneously, permitting 16 times higher throughput than existing planar patch clamp approach.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Quinn, MD 12251 S 80th Ave Ste 1630, Palos Heights, IL 60463-1256 Ph: (708) 923-3388 | Thomas Quinn, MD 12255 S 80th Ave, Palos Heights, IL 60463-1270 Ph: (708) 923-3388 |
News Archive
Public health officials in New York City have launched a successful program to locate HIV-positive patients who have been "lost to follow-up" and reconnect them with treatment services, reports a study published in AIDS, official journal of the International AIDS Society.
For small business owners, technicians, laboratory managers and method developers, a new FT-NIR spectrometer is designed to bring rapid and reliable analysis for quality control and material verification.
Aduro BioTech, a clinical-stage immunotherapy company, announced today the issuance of two important patents, the formation of a distinguished scientific advisory board, the addition of key members to its Board of Directors, and the reporting of preliminary top line long-term survival data from a Phase 1 clinical trial with 2 year follow-up.
"The goal of the WHO - amplified ... in the Universal Declaration of Human Rights - is to ensure the attainment by the entire world's people of the highest possible level of health," Calum Macpherson, director and vice president of the Windward Islands Research and Education Foundation, writes in a Devex opinion piece.
Researchers from A*STAR Institute of Microelectronics (IME) have developed a lateral silicon-based drug screening tool that has demonstrated simultaneous capture of 12 individual cells – 12 times higher throughput than conventional patch clamping. The device can be scaled up to allow 1536 cell-recordings simultaneously, permitting 16 times higher throughput than existing planar patch clamp approach.
› Verified 2 days ago
Dr. Maitrayee Sundaresan Vadali, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 12251 S 80th Ave Ste 1520, Palos Heights, IL 60463 Phone: 708-923-4200 Fax: 708-923-4201 | |
Dr. Natalie Pitaro, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 12255 S 80th Ave, Palos Heights, IL 60463 Phone: 708-923-7874 Fax: 708-923-7876 | |
Dr. Abdul-hamid Mohammed Shahbain, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 12508 S Harlem Ave, Suite C, Palos Heights, IL 60463 Phone: 708-671-1685 Fax: 708-671-1695 | |
Sandhya Nagubadi, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 12800 S Ridgeland Ave Ste E, Palos Heights, IL 60463 Phone: 708-429-3700 Fax: 708-429-4460 | |
Arpana Paruchuri, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 12251 S 80th Ave, Palos Heights, IL 60463 Phone: 708-923-4529 | |
Chaher Hussain Alhandalous, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 12251 S. 80th Avenue, Palos Heights, IL 60463 Phone: 708-923-5869 Fax: 708-923-5859 | |
Kathryn Rose Mailhiot, APRN, CNP Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 12251 S 80th Ave, Palos Heights, IL 60463 Phone: 708-923-4963 Fax: 708-923-4283 |